AHA Comments on Medicare Advantage Proposed Rule for Contract Years 2021 and 2022

The American Hospital Association appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ proposed regulation regarding policy and technical changes to Medicare Advantage and Part D prescription drug program for Contract Years 2021 and 2022. The proposed rule addresses a number of areas of importance to hospitals and health systems, including those that sponsor MA plans.

The AHA supports CMS’s efforts to provide plans with additional flexibilities to facilitate innovation under the MA program to meet the unique and complex needs of the Medicare population. We, however, have concerns regarding several proposals addressing network adequacy in the proposed rule.

Related Resources

AHA comments on CMS’ proposed rule on prior authorization.
AHA Center for Health Innovation Market Scan
While it’s been difficult this year to predict what the next month will bring for health care, a few longer-term impacts are much clearer, including how…
AHA Center for Health Innovation Market Scan
COVID-19 has upended priorities for hospitals and health systems in nearly all areas of leadership focus, including digital health innovation. Expanding and…
AHA Center for Health Innovation Market Scan
Recent research into telehealth adoption found that providers’ satisfaction was directly proportional to the amount of input they had in program design and…
Special Bulletin
The Centers for Medicare & Medicaid Services (CMS) Nov. 25 announced several flexibilities aimed at allowing health care services to be provided outside of…
Leadership Rounds